Back To Back FDA Approval For Takeda Within Two Days,

Back To Back FDA Approval For Takeda Within Two Days, Secures Green Signal For Rare Blood Disorder Therapy

Upworthy

Published 10 Nov 2023

The FDA approved Takeda Pharmaceutical Co Ltd's TAK Adzynma, a recombinant (genetically engineered) protein product indicated for prophylactic (preventive) or on-demand enzyme replacement therapy (ERT) in adult and pediatric patients with congenital thrombotic thrombocytopenic purpura (cTTP). cTTP…

#fda #ert #cttp #adamts13 #adzynma #ttp #takeda #fruzaqla #priorityreview #tak

Full Article

Back To Back FDA Approval For Takeda Within Two Days, Secures Green Signal For Rare Blood Disorder Therapy

Back To Back FDA Approval For Takeda Within Two Days, Secures Green Signal For Rare Blood Disorder Therapy

You might like